Annual Cash & Cash Equivalents
$74.02 M
-$81.37 M-52.37%
December 31, 2023
Summary
- As of February 7, 2025, SLDB annual cash & cash equivalents is $74.02 million, with the most recent change of -$81.37 million (-52.37%) on December 31, 2023.
- During the last 3 years, SLDB annual cash & cash equivalents has fallen by -$80.73 million (-52.17%).
- SLDB annual cash & cash equivalents is now -52.37% below its all-time high of $155.38 million, reached on December 31, 2022.
Performance
SLDB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$64.39 M
-$31.46 M-32.82%
September 30, 2024
Summary
- As of February 7, 2025, SLDB quarterly cash and cash equivalents is $64.39 million, with the most recent change of -$31.46 million (-32.82%) on September 30, 2024.
- Over the past year, SLDB quarterly cash and cash equivalents has dropped by -$9.62 million (-13.00%).
- SLDB quarterly cash and cash equivalents is now -76.02% below its all-time high of $268.50 million, reached on March 31, 2021.
Performance
SLDB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SLDB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.4% | -13.0% |
| 3 y3 years | -52.2% | -29.7% |
| 5 y5 years | -14.3% | -29.7% |
SLDB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.4% | at low | -60.9% | +32.0% |
| 5 y | 5-year | -52.4% | at low | -76.0% | +159.7% |
| alltime | all time | -52.4% | +864.0% | -76.0% | +738.7% |
Solid Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $64.39 M(-32.8%) |
| Jun 2024 | - | $95.85 M(-18.5%) |
| Mar 2024 | - | $117.57 M(+58.9%) |
| Dec 2023 | $74.02 M(-52.4%) | $74.02 M(+50.9%) |
| Sep 2023 | - | $49.04 M(-46.4%) |
| Jun 2023 | - | $91.57 M(-44.4%) |
| Mar 2023 | - | $164.65 M(+6.0%) |
| Dec 2022 | $155.38 M(+30.4%) | $155.38 M(+218.5%) |
| Sep 2022 | - | $48.79 M(-10.2%) |
| Jun 2022 | - | $54.31 M(-58.1%) |
| Mar 2022 | - | $129.71 M(+8.9%) |
| Dec 2021 | $119.14 M(-23.0%) | $119.14 M(+8.6%) |
| Sep 2021 | - | $109.68 M(-45.3%) |
| Jun 2021 | - | $200.61 M(-25.3%) |
| Mar 2021 | - | $268.50 M(+73.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $154.74 M(+103.5%) | $154.74 M(+524.0%) |
| Sep 2020 | - | $24.80 M(-38.7%) |
| Jun 2020 | - | $40.44 M(-24.0%) |
| Mar 2020 | - | $53.19 M(-30.1%) |
| Dec 2019 | $76.04 M(-12.0%) | $76.04 M(-19.7%) |
| Sep 2019 | - | $94.72 M(+82.7%) |
| Jun 2019 | - | $51.84 M(-4.0%) |
| Mar 2019 | - | $53.99 M(-37.5%) |
| Dec 2018 | $86.37 M(+65.8%) | $86.37 M(-33.1%) |
| Sep 2018 | - | $129.14 M(-11.4%) |
| Jun 2018 | - | $145.82 M(-11.5%) |
| Mar 2018 | - | $164.77 M(+216.4%) |
| Dec 2017 | $52.08 M(+578.3%) | $52.08 M(+246.8%) |
| Sep 2017 | - | $15.02 M(+95.6%) |
| Dec 2016 | $7.68 M(-73.1%) | $7.68 M |
| Dec 2015 | $28.59 M | - |
FAQ
- What is Solid Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Solid Biosciences?
- What is Solid Biosciences annual cash & cash equivalents year-on-year change?
- What is Solid Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Solid Biosciences?
- What is Solid Biosciences quarterly cash and cash equivalents year-on-year change?
What is Solid Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SLDB is $74.02 M
What is the all time high annual cash & cash equivalents for Solid Biosciences?
Solid Biosciences all-time high annual cash & cash equivalents is $155.38 M
What is Solid Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, SLDB annual cash & cash equivalents has changed by -$81.37 M (-52.37%)
What is Solid Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SLDB is $64.39 M
What is the all time high quarterly cash and cash equivalents for Solid Biosciences?
Solid Biosciences all-time high quarterly cash and cash equivalents is $268.50 M
What is Solid Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SLDB quarterly cash and cash equivalents has changed by -$9.62 M (-13.00%)